Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Breast Cancer Treatment
Adrienne G. Waks, Eric P. Winer
JAMA (2019) Vol. 321, Iss. 3, pp. 288-288
Closed Access | Times Cited: 3647

Showing 1-25 of 3647 citing articles:

Breast cancer statistics, 2019
Carol DeSantis, Jiemin Ma, Mia M. Gaudet, et al.
CA A Cancer Journal for Clinicians (2019) Vol. 69, Iss. 6, pp. 438-451
Open Access | Times Cited: 2819
Breast Cancer Statistics, 2022
Angela N. Giaquinto, Hyuna Sung, Kimberly D. Miller, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 6, pp. 524-541
Open Access | Times Cited: 1668
Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer
Balázs Győrffy
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4101-4109
Open Access | Times Cited: 1346
Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study
Emily Heer, Andrew Harper, Noah Escandor, et al.
The Lancet Global Health (2020) Vol. 8, Iss. 8, pp. e1027-e1037
Open Access | Times Cited: 664
MicroRNAs and complex diseases: from experimental results to computational models
Xing Chen, Di Xie, Qi Zhao, et al.
Briefings in Bioinformatics (2017) Vol. 20, Iss. 2, pp. 515-539
Closed Access | Times Cited: 581
Sex differences in heart failure
Carolyn S.P. Lam, Clare Arnott, A. Beale, et al.
European Heart Journal (2019) Vol. 40, Iss. 47, pp. 3859-3868c
Open Access | Times Cited: 580
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Jiang‐Jiang Qin, Yan Li, Jia Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 308
Personalized early detection and prevention of breast cancer: ENVISION consensus statement
Nora Pashayan, Antonis C. Antoniou, Urška Ivanuš, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 11, pp. 687-705
Open Access | Times Cited: 306
Nanoscale Covalent Organic Framework for Combinatorial Antitumor Photodynamic and Photothermal Therapy
Qun Guan, Lele Zhou, Yanan Li, et al.
ACS Nano (2019) Vol. 13, Iss. 11, pp. 13304-13316
Closed Access | Times Cited: 284
CircRNAs: role in human diseases and potential use as biomarkers
Lorena Verduci, Emilio Tarcitano, Sabrina Strano, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 278
Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
Yi-Zhou Jiang, Yin Liu, Yi Xiao, et al.
Cell Research (2020) Vol. 31, Iss. 2, pp. 178-186
Open Access | Times Cited: 206
Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer
Maria Alice Franzoi, Elisa Agostinetto, Marta Perachino, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 7, pp. e303-e313
Open Access | Times Cited: 200
American Cancer Society's report on the status of cancer disparities in the United States, 2021
Farhad Islami, Carmen E. Guerra, Adair K. Minihan, et al.
CA A Cancer Journal for Clinicians (2021) Vol. 72, Iss. 2, pp. 112-143
Open Access | Times Cited: 188
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies
Denise M. Wolf, Christina Yau, Julia Wulfkuhle, et al.
Cancer Cell (2022) Vol. 40, Iss. 6, pp. 609-623.e6
Open Access | Times Cited: 188
An expanded universe of cancer targets
William C. Hahn, Joel S. Bader, Theodore P. Braun, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1142-1155
Open Access | Times Cited: 181
Recent advances in nanoparticle-based photothermal therapy for breast cancer
Sania Ghobadi Alamdari, Mohammad Amini, Nazila Jalilzadeh, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 269-303
Closed Access | Times Cited: 175
Multienzyme-like Reactivity Cooperatively Impairs Glutathione Peroxidase 4 and Ferroptosis Suppressor Protein 1 Pathways in Triple-Negative Breast Cancer for Sensitized Ferroptosis Therapy
Ke Li, Chuanchuan Lin, Menghuan Li, et al.
ACS Nano (2022) Vol. 16, Iss. 2, pp. 2381-2398
Closed Access | Times Cited: 174
The mechanism of anticancer action and potential clinical use of kaempferol in the treatment of breast cancer
Xueni Wang, Yuting Yang, Yating An, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 117, pp. 109086-109086
Open Access | Times Cited: 167
Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework
Weilun Pan, Yong Tan, Wei Meng, et al.
Biomaterials (2022) Vol. 283, pp. 121449-121449
Closed Access | Times Cited: 160
LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway
Kun Qiao, Shipeng Ning, Lin Wan, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 158
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
Léa Clusan, François Ferrière, Gilles Flouriot, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6834-6834
Open Access | Times Cited: 154
Hyperinsulinemia in Obesity, Inflammation, and Cancer
Anni Zhang, Elizabeth A. Wellberg, Janel L. Kopp, et al.
Diabetes & Metabolism Journal (2021) Vol. 45, Iss. 3, pp. 285-311
Open Access | Times Cited: 153
TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines
Ashkan Shahbandi, Hoang Duc Nguyen, James G. Jackson
Trends in cancer (2020) Vol. 6, Iss. 2, pp. 98-110
Open Access | Times Cited: 147
Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy
Chunai Gong, Xiaoyan Yu, Benming You, et al.
Journal of Nanobiotechnology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 147
D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1
Ruonan Zhang, Yajing Yang, Wenjing Dong, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 8
Open Access | Times Cited: 147
Page 1 - Next Page

Scroll to top